iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by WealthCare Investment Partners LLC

WealthCare Investment Partners LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the third quarter, Holdings Channel.com reports. The institutional investor owned 10,252 shares of the financial services provider’s stock after acquiring an additional 281 shares during the period. WealthCare Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,458,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of IBB. Blue Fin Capital Inc. boosted its stake in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak boosted its stake in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after purchasing an additional 75 shares during the last quarter. Main Street Financial Solutions LLC grew its holdings in shares of iShares Biotechnology ETF by 1.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after buying an additional 82 shares in the last quarter. Perkins Coie Trust Co raised its position in shares of iShares Biotechnology ETF by 0.3% in the second quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock valued at $3,457,000 after buying an additional 83 shares during the last quarter. Finally, HCR Wealth Advisors lifted its stake in shares of iShares Biotechnology ETF by 0.6% during the second quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock valued at $1,847,000 after buying an additional 83 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.6 %

IBB stock opened at $143.00 on Wednesday. The company has a 50 day moving average price of $145.27 and a two-hundred day moving average price of $139.22. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.